IDEXX Laboratories, Inc.
General ticker "IDXX" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $35.2B
IDEXX Laboratories, Inc. does not follow the US Stock Market performance with the rate: -16.2%.
Estimated limits based on current volatility of 1.5%: low 404.40$, high 416.35$
Factors to consider:
- Company included in S&P500 list
- Current price 21.2% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [524.02$, 719.55$]
- 2024-12-30 to 2025-12-30 estimated range: [577.59$, 786.83$]
Financial Metrics affecting the IDXX estimates:
- Positive: Non-GAAP EPS, $ of 10.07 > 2.29
- Positive: -3.48 < Investing cash flow per share, $ of -1.51
- Negative: Operating cash flow per share per price, % of 2.08 <= 2.35
- Positive: Inventory ratio change, % of -0.35 <= 0
- Positive: Interest expense per share, $ of 0.50 <= 0.74
- Positive: Operating profit margin, % of 29.97 > 19.51
- Negative: 0 < Industry inventory ratio change (median), % of 0.19
Short-term IDXX quotes
Long-term IDXX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $3,215.36MM | $3,367.32MM | $3,660.95MM |
| Operating Expenses | $2,283.33MM | $2,468.56MM | $2,563.82MM |
| Operating Income | $932.03MM | $898.76MM | $1,097.13MM |
| Non-Operating Income | $-29.37MM | $-38.79MM | $-35.95MM |
| Interest Expense | $29.37MM | $38.79MM | $41.58MM |
| R&D Expense | $161.01MM | $254.82MM | $190.95MM |
| Income(Loss) | $902.65MM | $859.97MM | $1,061.18MM |
| Taxes | $157.81MM | $180.88MM | $216.13MM |
| Profit(Loss) | $744.84MM | $679.09MM | $845.04MM |
| Stockholders Equity | $689.99MM | $608.74MM | $1,484.53MM |
| Inventory | $269.03MM | $367.82MM | $380.28MM |
| Assets | $2,437.20MM | $2,746.76MM | $3,259.93MM |
| Operating Cash Flow | $755.55MM | $542.98MM | $906.51MM |
| Capital expenditure | $119.55MM | $148.84MM | $133.63MM |
| Investing Cash Flow | $-292.97MM | $-195.35MM | $-125.25MM |
| Financing Cash Flow | $-697.41MM | $-370.94MM | $-442.00MM |
| Earnings Per Share* | $8.74 | $8.12 | $10.17 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.